Status:
COMPLETED
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?
Lead Sponsor:
Huazhong University of Science and Technology
Collaborating Sponsors:
Ministry of Health, China
Hepatic Surgery Clinical Research Centre of Hubei, China
Conditions:
Cholangiocarcinoma
Surgical Treatment
Eligibility:
All Genders
26-72 years
Phase:
NA
Brief Summary
The investigators conducted a prospective study to determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in 138 patients with hilar cholangiocarcinoma. In...
Detailed Description
Objective: To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC). Summary Background Data: For HC treat...
Eligibility Criteria
Inclusion
- Criteria for resectability were absence of peritoneal or liver metastases, tumor extension to beyond secondary biliary branches bilaterally, tumor extension to secondary portal venous branches bilaterally
Exclusion
- not in accordance with the above criteria
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00733200
Last Update
December 11 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.